IMNM
Price
$10.96
Change
-$0.01 (-0.09%)
Updated
Dec 23, 04:59 PM (EDT)
93 days until earnings call
XNCR
Price
$24.57
Change
+$0.44 (+1.82%)
Updated
Dec 23, 04:59 PM (EDT)
70 days until earnings call
Ad is loading...

IMNM vs XNCR

Header iconIMNM vs XNCR Comparison
Open Charts IMNM vs XNCRBanner chart's image
Immunome
Price$10.96
Change-$0.01 (-0.09%)
Volume$22.41K
CapitalizationN/A
Xencor
Price$24.57
Change+$0.44 (+1.82%)
Volume$6.67K
CapitalizationN/A
IMNM vs XNCR Comparison Chart
Loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNM vs. XNCR commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Hold and XNCR is a Hold.

COMPARISON
Comparison
Dec 24, 2024
Stock price -- (IMNM: $10.97 vs. XNCR: $24.13)
Brand notoriety: IMNM and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 182% vs. XNCR: 645%
Market capitalization -- IMNM: $685.96M vs. XNCR: $1.72B
IMNM [@Biotechnology] is valued at $685.96M. XNCR’s [@Biotechnology] market capitalization is $1.72B. The market cap for tickers in the [@Biotechnology] industry ranges from $363.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, XNCR is a better buy in the long-term than IMNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 4 TA indicator(s) are bullish while XNCR’s TA Score has 4 bullish TA indicator(s).

  • IMNM’s TA Score: 4 bullish, 5 bearish.
  • XNCR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, XNCR is a better buy in the short-term than IMNM.

Price Growth

IMNM (@Biotechnology) experienced а -12.80% price change this week, while XNCR (@Biotechnology) price change was +0.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.79%. For the same industry, the average monthly price growth was -2.59%, and the average quarterly price growth was +3.59%.

Reported Earning Dates

IMNM is expected to report earnings on Mar 26, 2025.

XNCR is expected to report earnings on Mar 03, 2025.

Industries' Descriptions

@Biotechnology (-1.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XNCR($1.69B) has a higher market cap than IMNM($686M). XNCR YTD gains are higher at: 13.660 vs. IMNM (2.523). IMNM has higher annual earnings (EBITDA): -109.95M vs. XNCR (-198.91M). XNCR has more cash in the bank: 543M vs. IMNM (240M). IMNM has less debt than XNCR: IMNM (2.72M) vs XNCR (86.6M). XNCR has higher revenues than IMNM: XNCR (85.2M) vs IMNM (10.1M).
IMNMXNCRIMNM / XNCR
Capitalization686M1.69B41%
EBITDA-109.95M-198.91M55%
Gain YTD2.52313.66018%
P/E RatioN/AN/A-
Revenue10.1M85.2M12%
Total Cash240M543M44%
Total Debt2.72M86.6M3%
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMNMXNCR
RSI
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
74%
Momentum
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
82%
MACD
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
75%
Advances
ODDS (%)
Bullish Trend 15 days ago
81%
Bullish Trend 4 days ago
72%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 11 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
69%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
81%
View a ticker or compare two or three
Ad is loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYAWX103.091.80
+1.78%
Rydex S&P 500 Pure Growth H
INIIX14.870.15
+1.02%
VanEck International Investors Gold I
ACFGX75.980.70
+0.93%
American Century Focused Dynamic Gr G
JABLX51.500.41
+0.80%
Janus Henderson VIT Balanced Instl
HIISX13.57-0.29
-2.09%
Harbor International Small Cap Investor

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with BEAM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-0.99%
BEAM - IMNM
46%
Loosely correlated
+8.04%
INZY - IMNM
46%
Loosely correlated
+6.41%
ATXS - IMNM
44%
Loosely correlated
+1.16%
RXRX - IMNM
43%
Loosely correlated
-0.99%
JSPR - IMNM
43%
Loosely correlated
+0.19%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with RLAY. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
+0.50%
RLAY - XNCR
53%
Loosely correlated
-2.35%
VCYT - XNCR
52%
Loosely correlated
+4.66%
ERAS - XNCR
49%
Loosely correlated
+3.67%
PGEN - XNCR
45%
Loosely correlated
+5.07%
BEAM - XNCR
44%
Loosely correlated
+8.04%
More